ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Precision Medicine Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-33A5667
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Precision Medicine Market Insights Forecast to 2028
BUY CHAPTERS

Global Oncology Precision Medicine Market Research Report 2025

Code: QYRE-Auto-33A5667
Report
June 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Agilent Technologies
ALMAC
Angle plc
Asuragen
BGI Group
Bio Rad Laboratories
bioMérieux
Bristol–Myers Squibb
Roche Holding AG
Gilead Sciences
Illumina Inc
Konica Minolta
LabCorp
MDxHealth
Myriad Genetics
Novartis
OPKO Health
Pacific Biosciences
Quest Diagnostics
Qiagen NV

Oncology Precision Medicine Market Size

The global market for Oncology Precision Medicine was valued at US$ 38530 million in the year 2024 and is projected to reach a revised size of US$ 51520 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Oncology Precision Medicine Market

Oncology Precision Medicine Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Oncology Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Precision Medicine.
The Oncology Precision Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Precision Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Precision Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oncology Precision Medicine Market Report

Report Metric Details
Report Name Oncology Precision Medicine Market
Accounted market size in year US$ 38530 million
Forecasted market size in 2031 US$ 51520 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioMérieux, Bristol Myers Squibb, Roche Holding AG, Gilead Sciences, Illumina, Konica Minolta, LabCorp, MDxHealth, Myriad Genetics, Novartis, OPKO Health, Pacific Biosciences, Quest Diagnostics, Qiagen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oncology Precision Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oncology Precision Medicine Market growing?

Ans: The Oncology Precision Medicine Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Oncology Precision Medicine Market size in 2031?

Ans: The Oncology Precision Medicine Market size in 2031 will be US$ 51520 million.

Who are the main players in the Oncology Precision Medicine Market report?

Ans: The main players in the Oncology Precision Medicine Market are Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioMérieux, Bristol Myers Squibb, Roche Holding AG, Gilead Sciences, Illumina, Konica Minolta, LabCorp, MDxHealth, Myriad Genetics, Novartis, OPKO Health, Pacific Biosciences, Quest Diagnostics, Qiagen

What are the Application segmentation covered in the Oncology Precision Medicine Market report?

Ans: The Applications covered in the Oncology Precision Medicine Market report are Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Other Cancer

What are the Type segmentation covered in the Oncology Precision Medicine Market report?

Ans: The Types covered in the Oncology Precision Medicine Market report are Applied Sciences, Precision Diagnostics, Digital Health and Information Technology, Precision Therapeutics

Recommended Reports

Cancer Diagnostics

Cancer Therapeutics

Medical Equipment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Precision Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Applied Sciences
1.2.3 Precision Diagnostics
1.2.4 Digital Health and Information Technology
1.2.5 Precision Therapeutics
1.3 Market by Application
1.3.1 Global Oncology Precision Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Prostate Cancer
1.3.6 Cervical Cancer
1.3.7 Other Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Precision Medicine Market Perspective (2020-2031)
2.2 Global Oncology Precision Medicine Growth Trends by Region
2.2.1 Global Oncology Precision Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology Precision Medicine Historic Market Size by Region (2020-2025)
2.2.3 Oncology Precision Medicine Forecasted Market Size by Region (2026-2031)
2.3 Oncology Precision Medicine Market Dynamics
2.3.1 Oncology Precision Medicine Industry Trends
2.3.2 Oncology Precision Medicine Market Drivers
2.3.3 Oncology Precision Medicine Market Challenges
2.3.4 Oncology Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Precision Medicine Players by Revenue
3.1.1 Global Top Oncology Precision Medicine Players by Revenue (2020-2025)
3.1.2 Global Oncology Precision Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology Precision Medicine Revenue
3.4 Global Oncology Precision Medicine Market Concentration Ratio
3.4.1 Global Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Precision Medicine Revenue in 2024
3.5 Global Key Players of Oncology Precision Medicine Head office and Area Served
3.6 Global Key Players of Oncology Precision Medicine, Product and Application
3.7 Global Key Players of Oncology Precision Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Precision Medicine Breakdown Data by Type
4.1 Global Oncology Precision Medicine Historic Market Size by Type (2020-2025)
4.2 Global Oncology Precision Medicine Forecasted Market Size by Type (2026-2031)
5 Oncology Precision Medicine Breakdown Data by Application
5.1 Global Oncology Precision Medicine Historic Market Size by Application (2020-2025)
5.2 Global Oncology Precision Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology Precision Medicine Market Size (2020-2031)
6.2 North America Oncology Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology Precision Medicine Market Size by Country (2020-2025)
6.4 North America Oncology Precision Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Precision Medicine Market Size (2020-2031)
7.2 Europe Oncology Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology Precision Medicine Market Size by Country (2020-2025)
7.4 Europe Oncology Precision Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Precision Medicine Market Size (2020-2031)
8.2 Asia-Pacific Oncology Precision Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology Precision Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology Precision Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Precision Medicine Market Size (2020-2031)
9.2 Latin America Oncology Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology Precision Medicine Market Size by Country (2020-2025)
9.4 Latin America Oncology Precision Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Precision Medicine Market Size (2020-2031)
10.2 Middle East & Africa Oncology Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology Precision Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology Precision Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Oncology Precision Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Oncology Precision Medicine Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Oncology Precision Medicine Introduction
11.2.4 Agilent Technologies Revenue in Oncology Precision Medicine Business (2020-2025)
11.2.5 Agilent Technologies Recent Development
11.3 Almac
11.3.1 Almac Company Details
11.3.2 Almac Business Overview
11.3.3 Almac Oncology Precision Medicine Introduction
11.3.4 Almac Revenue in Oncology Precision Medicine Business (2020-2025)
11.3.5 Almac Recent Development
11.4 ANGLE plc
11.4.1 ANGLE plc Company Details
11.4.2 ANGLE plc Business Overview
11.4.3 ANGLE plc Oncology Precision Medicine Introduction
11.4.4 ANGLE plc Revenue in Oncology Precision Medicine Business (2020-2025)
11.4.5 ANGLE plc Recent Development
11.5 Asuragen
11.5.1 Asuragen Company Details
11.5.2 Asuragen Business Overview
11.5.3 Asuragen Oncology Precision Medicine Introduction
11.5.4 Asuragen Revenue in Oncology Precision Medicine Business (2020-2025)
11.5.5 Asuragen Recent Development
11.6 BGI Group
11.6.1 BGI Group Company Details
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Oncology Precision Medicine Introduction
11.6.4 BGI Group Revenue in Oncology Precision Medicine Business (2020-2025)
11.6.5 BGI Group Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Oncology Precision Medicine Introduction
11.7.4 Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 BioMérieux
11.8.1 BioMérieux Company Details
11.8.2 BioMérieux Business Overview
11.8.3 BioMérieux Oncology Precision Medicine Introduction
11.8.4 BioMérieux Revenue in Oncology Precision Medicine Business (2020-2025)
11.8.5 BioMérieux Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Details
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Oncology Precision Medicine Introduction
11.9.4 Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2020-2025)
11.9.5 Bristol Myers Squibb Recent Development
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Details
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Oncology Precision Medicine Introduction
11.10.4 Roche Holding AG Revenue in Oncology Precision Medicine Business (2020-2025)
11.10.5 Roche Holding AG Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Oncology Precision Medicine Introduction
11.11.4 Gilead Sciences Revenue in Oncology Precision Medicine Business (2020-2025)
11.11.5 Gilead Sciences Recent Development
11.12 Illumina
11.12.1 Illumina Company Details
11.12.2 Illumina Business Overview
11.12.3 Illumina Oncology Precision Medicine Introduction
11.12.4 Illumina Revenue in Oncology Precision Medicine Business (2020-2025)
11.12.5 Illumina Recent Development
11.13 Konica Minolta
11.13.1 Konica Minolta Company Details
11.13.2 Konica Minolta Business Overview
11.13.3 Konica Minolta Oncology Precision Medicine Introduction
11.13.4 Konica Minolta Revenue in Oncology Precision Medicine Business (2020-2025)
11.13.5 Konica Minolta Recent Development
11.14 LabCorp
11.14.1 LabCorp Company Details
11.14.2 LabCorp Business Overview
11.14.3 LabCorp Oncology Precision Medicine Introduction
11.14.4 LabCorp Revenue in Oncology Precision Medicine Business (2020-2025)
11.14.5 LabCorp Recent Development
11.15 MDxHealth
11.15.1 MDxHealth Company Details
11.15.2 MDxHealth Business Overview
11.15.3 MDxHealth Oncology Precision Medicine Introduction
11.15.4 MDxHealth Revenue in Oncology Precision Medicine Business (2020-2025)
11.15.5 MDxHealth Recent Development
11.16 Myriad Genetics
11.16.1 Myriad Genetics Company Details
11.16.2 Myriad Genetics Business Overview
11.16.3 Myriad Genetics Oncology Precision Medicine Introduction
11.16.4 Myriad Genetics Revenue in Oncology Precision Medicine Business (2020-2025)
11.16.5 Myriad Genetics Recent Development
11.17 Novartis
11.17.1 Novartis Company Details
11.17.2 Novartis Business Overview
11.17.3 Novartis Oncology Precision Medicine Introduction
11.17.4 Novartis Revenue in Oncology Precision Medicine Business (2020-2025)
11.17.5 Novartis Recent Development
11.18 OPKO Health
11.18.1 OPKO Health Company Details
11.18.2 OPKO Health Business Overview
11.18.3 OPKO Health Oncology Precision Medicine Introduction
11.18.4 OPKO Health Revenue in Oncology Precision Medicine Business (2020-2025)
11.18.5 OPKO Health Recent Development
11.19 Pacific Biosciences
11.19.1 Pacific Biosciences Company Details
11.19.2 Pacific Biosciences Business Overview
11.19.3 Pacific Biosciences Oncology Precision Medicine Introduction
11.19.4 Pacific Biosciences Revenue in Oncology Precision Medicine Business (2020-2025)
11.19.5 Pacific Biosciences Recent Development
11.20 Quest Diagnostics
11.20.1 Quest Diagnostics Company Details
11.20.2 Quest Diagnostics Business Overview
11.20.3 Quest Diagnostics Oncology Precision Medicine Introduction
11.20.4 Quest Diagnostics Revenue in Oncology Precision Medicine Business (2020-2025)
11.20.5 Quest Diagnostics Recent Development
11.21 Qiagen
11.21.1 Qiagen Company Details
11.21.2 Qiagen Business Overview
11.21.3 Qiagen Oncology Precision Medicine Introduction
11.21.4 Qiagen Revenue in Oncology Precision Medicine Business (2020-2025)
11.21.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Agilent Technologies
ALMAC
Angle plc
Asuragen
BGI Group
Bio Rad Laboratories
bioMérieux
Bristol–Myers Squibb
Roche Holding AG
Gilead Sciences
Illumina Inc
Konica Minolta
LabCorp
MDxHealth
Myriad Genetics
Novartis
OPKO Health
Pacific Biosciences
Quest Diagnostics
Qiagen NV
List of Tables
 Table 1. Global Oncology Precision Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Applied Sciences
 Table 3. Key Players of Precision Diagnostics
 Table 4. Key Players of Digital Health and Information Technology
 Table 5. Key Players of Precision Therapeutics
 Table 6. Global Oncology Precision Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Oncology Precision Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Oncology Precision Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Oncology Precision Medicine Market Share by Region (2020-2025)
 Table 10. Global Oncology Precision Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Oncology Precision Medicine Market Share by Region (2026-2031)
 Table 12. Oncology Precision Medicine Market Trends
 Table 13. Oncology Precision Medicine Market Drivers
 Table 14. Oncology Precision Medicine Market Challenges
 Table 15. Oncology Precision Medicine Market Restraints
 Table 16. Global Oncology Precision Medicine Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Oncology Precision Medicine Market Share by Players (2020-2025)
 Table 18. Global Top Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Precision Medicine as of 2024)
 Table 19. Ranking of Global Top Oncology Precision Medicine Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Oncology Precision Medicine Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Oncology Precision Medicine, Headquarters and Area Served
 Table 22. Global Key Players of Oncology Precision Medicine, Product and Application
 Table 23. Global Key Players of Oncology Precision Medicine, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Oncology Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Oncology Precision Medicine Revenue Market Share by Type (2020-2025)
 Table 27. Global Oncology Precision Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Oncology Precision Medicine Revenue Market Share by Type (2026-2031)
 Table 29. Global Oncology Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Oncology Precision Medicine Revenue Market Share by Application (2020-2025)
 Table 31. Global Oncology Precision Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Oncology Precision Medicine Revenue Market Share by Application (2026-2031)
 Table 33. North America Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Oncology Precision Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Oncology Precision Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Oncology Precision Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Oncology Precision Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Oncology Precision Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Oncology Precision Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Oncology Precision Medicine Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Oncology Precision Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oncology Precision Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Oncology Precision Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Oncology Precision Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Abbott Laboratories Company Details
 Table 49. Abbott Laboratories Business Overview
 Table 50. Abbott Laboratories Oncology Precision Medicine Product
 Table 51. Abbott Laboratories Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 52. Abbott Laboratories Recent Development
 Table 53. Agilent Technologies Company Details
 Table 54. Agilent Technologies Business Overview
 Table 55. Agilent Technologies Oncology Precision Medicine Product
 Table 56. Agilent Technologies Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 57. Agilent Technologies Recent Development
 Table 58. Almac Company Details
 Table 59. Almac Business Overview
 Table 60. Almac Oncology Precision Medicine Product
 Table 61. Almac Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 62. Almac Recent Development
 Table 63. ANGLE plc Company Details
 Table 64. ANGLE plc Business Overview
 Table 65. ANGLE plc Oncology Precision Medicine Product
 Table 66. ANGLE plc Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 67. ANGLE plc Recent Development
 Table 68. Asuragen Company Details
 Table 69. Asuragen Business Overview
 Table 70. Asuragen Oncology Precision Medicine Product
 Table 71. Asuragen Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 72. Asuragen Recent Development
 Table 73. BGI Group Company Details
 Table 74. BGI Group Business Overview
 Table 75. BGI Group Oncology Precision Medicine Product
 Table 76. BGI Group Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 77. BGI Group Recent Development
 Table 78. Bio-Rad Laboratories Company Details
 Table 79. Bio-Rad Laboratories Business Overview
 Table 80. Bio-Rad Laboratories Oncology Precision Medicine Product
 Table 81. Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 82. Bio-Rad Laboratories Recent Development
 Table 83. BioMérieux Company Details
 Table 84. BioMérieux Business Overview
 Table 85. BioMérieux Oncology Precision Medicine Product
 Table 86. BioMérieux Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 87. BioMérieux Recent Development
 Table 88. Bristol Myers Squibb Company Details
 Table 89. Bristol Myers Squibb Business Overview
 Table 90. Bristol Myers Squibb Oncology Precision Medicine Product
 Table 91. Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 92. Bristol Myers Squibb Recent Development
 Table 93. Roche Holding AG Company Details
 Table 94. Roche Holding AG Business Overview
 Table 95. Roche Holding AG Oncology Precision Medicine Product
 Table 96. Roche Holding AG Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 97. Roche Holding AG Recent Development
 Table 98. Gilead Sciences Company Details
 Table 99. Gilead Sciences Business Overview
 Table 100. Gilead Sciences Oncology Precision Medicine Product
 Table 101. Gilead Sciences Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 102. Gilead Sciences Recent Development
 Table 103. Illumina Company Details
 Table 104. Illumina Business Overview
 Table 105. Illumina Oncology Precision Medicine Product
 Table 106. Illumina Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 107. Illumina Recent Development
 Table 108. Konica Minolta Company Details
 Table 109. Konica Minolta Business Overview
 Table 110. Konica Minolta Oncology Precision Medicine Product
 Table 111. Konica Minolta Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 112. Konica Minolta Recent Development
 Table 113. LabCorp Company Details
 Table 114. LabCorp Business Overview
 Table 115. LabCorp Oncology Precision Medicine Product
 Table 116. LabCorp Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 117. LabCorp Recent Development
 Table 118. MDxHealth Company Details
 Table 119. MDxHealth Business Overview
 Table 120. MDxHealth Oncology Precision Medicine Product
 Table 121. MDxHealth Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 122. MDxHealth Recent Development
 Table 123. Myriad Genetics Company Details
 Table 124. Myriad Genetics Business Overview
 Table 125. Myriad Genetics Oncology Precision Medicine Product
 Table 126. Myriad Genetics Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 127. Myriad Genetics Recent Development
 Table 128. Novartis Company Details
 Table 129. Novartis Business Overview
 Table 130. Novartis Oncology Precision Medicine Product
 Table 131. Novartis Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 132. Novartis Recent Development
 Table 133. OPKO Health Company Details
 Table 134. OPKO Health Business Overview
 Table 135. OPKO Health Oncology Precision Medicine Product
 Table 136. OPKO Health Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 137. OPKO Health Recent Development
 Table 138. Pacific Biosciences Company Details
 Table 139. Pacific Biosciences Business Overview
 Table 140. Pacific Biosciences Oncology Precision Medicine Product
 Table 141. Pacific Biosciences Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 142. Pacific Biosciences Recent Development
 Table 143. Quest Diagnostics Company Details
 Table 144. Quest Diagnostics Business Overview
 Table 145. Quest Diagnostics Oncology Precision Medicine Product
 Table 146. Quest Diagnostics Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 147. Quest Diagnostics Recent Development
 Table 148. Qiagen Company Details
 Table 149. Qiagen Business Overview
 Table 150. Qiagen Oncology Precision Medicine Product
 Table 151. Qiagen Revenue in Oncology Precision Medicine Business (2020-2025) & (US$ Million)
 Table 152. Qiagen Recent Development
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Oncology Precision Medicine Picture
 Figure 2. Global Oncology Precision Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oncology Precision Medicine Market Share by Type: 2024 VS 2031
 Figure 4. Applied Sciences Features
 Figure 5. Precision Diagnostics Features
 Figure 6. Digital Health and Information Technology Features
 Figure 7. Precision Therapeutics Features
 Figure 8. Global Oncology Precision Medicine Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Oncology Precision Medicine Market Share by Application: 2024 VS 2031
 Figure 10. Breast Cancer Case Studies
 Figure 11. Lung Cancer Case Studies
 Figure 12. Colorectal Cancer Case Studies
 Figure 13. Prostate Cancer Case Studies
 Figure 14. Cervical Cancer Case Studies
 Figure 15. Other Cancer Case Studies
 Figure 16. Oncology Precision Medicine Report Years Considered
 Figure 17. Global Oncology Precision Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Oncology Precision Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Oncology Precision Medicine Market Share by Region: 2024 VS 2031
 Figure 20. Global Oncology Precision Medicine Market Share by Players in 2024
 Figure 21. Global Top Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Precision Medicine as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Oncology Precision Medicine Revenue in 2024
 Figure 23. North America Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Oncology Precision Medicine Market Share by Country (2020-2031)
 Figure 25. United States Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Oncology Precision Medicine Market Share by Country (2020-2031)
 Figure 29. Germany Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Oncology Precision Medicine Market Share by Region (2020-2031)
 Figure 37. China Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Oncology Precision Medicine Market Share by Country (2020-2031)
 Figure 45. Mexico Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Oncology Precision Medicine Market Share by Country (2020-2031)
 Figure 49. Turkey Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Abbott Laboratories Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 53. Agilent Technologies Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 54. Almac Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 55. ANGLE plc Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 56. Asuragen Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 57. BGI Group Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 59. BioMérieux Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 60. Bristol Myers Squibb Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 61. Roche Holding AG Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 62. Gilead Sciences Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 63. Illumina Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 64. Konica Minolta Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 65. LabCorp Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 66. MDxHealth Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 67. Myriad Genetics Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 68. Novartis Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 69. OPKO Health Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 70. Pacific Biosciences Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 71. Quest Diagnostics Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 72. Qiagen Revenue Growth Rate in Oncology Precision Medicine Business (2020-2025)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Precision Medicine Solution Market
0 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiation Oncology Devices Market Research Report 2025
Global Home Use Medical Devices Market Insights Forecast to 2030
Global Home Use Medical Equipment Market Insights Forecast to 2030
Real World Evidence in Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Guidewires Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Radiopharmaceutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Isotopes for Nuclear Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Medical Device and Diagnostics Trials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Used Medical Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Big Data Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Potential Therapy Equipment Market Insights Forecast to 2030
Global 0 Market Research Report 2024
Global 0 Market Research Report 2024
Online Medical Consultation Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
NSCLC Mutation Gene Analysis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Management System for Healthcare Facilities Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Surgical Planning and Evaluation System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pregnancy Risk Calculation Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions